Home
About
FAQ
History (17)
Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol.
HLA-DR6 Antigen
Cognitive-behavioral therapy attenuates nociceptive responding in patients with fibromyalgia: a pilot study.
Fast-conducting mechanoreceptors contribute to withdrawal behavior in normal and nerve injured rats.
Targeting PCSK9 for therapeutic gains.
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting PCSK9 for therapeutic gains.
Shapiro MD, Fazio S, Tavori H. Targeting PCSK9 for therapeutic gains. Curr Atheroscler Rep. 2015 Apr; 17(4):499.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Anticholesteremic Agents
Cholesterol, LDL
Dyslipidemias
Humans
Hypercholesterolemia
Proprotein Convertases
Serine Endopeptidases
authors with profiles
Michael D. Shapiro DO, MCR